<DOC>
	<DOCNO>NCT02944461</DOCNO>
	<brief_summary>To determine Dapsone ( Aczone ) 7.5 % gel safe effective treatment acne trunk</brief_summary>
	<brief_title>Efficacy Safety Aczone 7.5 % Gel Treatment Truncal Acne Vulgaris</brief_title>
	<detailed_description>This open label pilot study determine safety efficacy Dapsone ( Aczone ) 7.5 % gel apply daily trunk acne . Subjects apply Dapsone 16 week .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>Male female subject race least 12 year age . Female subject childbearing potential must negative urine pregnancy test Baseline practice reliable method contraception throughout study . Truncal acne IGA score 3 . Able understand requirement study sign Informed Consent/HIPAA form . Female subject pregnant , breast feeding childbearing potential willing use reliable method birth control . Subjects allergy sensitivity component test medication . Subjects comply proper wash period prohibit medication . Evidence recent drug alcohol abuse . Skin disease /disorder might interfere diagnosis evaluation truncal acne . Exposure investigational drug within 30 day Baseline visit . Medical condition contraindicates subject 's participation study . History poor cooperation , noncompliance medical treatment unreliability .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>